TSY-0110 - Kadcyla (T-DM1) Biosimilar
Model: TSY-0110
Category: Biosimilars
Exhibitor: FORMOSA PHARMACEUTICALS , INC
Booth No: N/A
Characteristic
√ TSY-0110 is a biosimilar of ado-trastuzumab emtansine (Kadcyla®), the first-in-class ADC for HER2+ early breast cancer (EBC) and metastatistic breast cancer (MBC).
√ TSY-0110 is in late-preclinical development stages, planning for CTA filing and conduct phase I trial in 2024.
√ Formosa Pharmaceuticals is seeking interested parties for regional/global licensing or co-development.
Other Products
-
APP13007 - Clobetasol Propionate Ophthalmic Suspension 0.05% for the treatment of post-operative inflammation and pain following ocular surgery
-
APP13002 - Infectious Eye Diseases Treatment
-
APNT Nanoparticle Formulation Platform
Highest Rated Products
-
2ton Mixing and Melting Tank with Storage Tanks
-
Planetary Vacuum Mixer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Pneumatic Liquid Filling Machine
-
High Speed Mixing Machine
-
Powder Machine-High Speed Mixer / Granulator
-
VACUUM EMULSIFY MIXING EQUIPMENT (Bottom Homogenized Series)
-
SEMI-AUTOMATIC EYESHADOW PRESS MACHINE
-
In-Line Homogenizer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Absorbable Collagen Membrane
-
SuitNifty Scar Gel (Non-Sterile)
-
Life Fusion Collagen Wound Dressing
-
TISUCODETM Type II Collagen Capsules
-
Natural Marine Collagen
-
HUO-FU Collagen Probiotics
-
Collagen Freeze Crystal Set
-
Feelife Intensive Revitalizing Mask
-
Feelife Foaming Wash
-
Feelife Collagen Repair Cream
-
Antera 3D
-
Delfin
-
Focuskin
-
Vacuum emulsify mixer
-
Triplicity-cone mixer
-
High-speed mixing granulating machine
-
Kneading machine
-
Magnetic mixing tank
-
High speed powder mixer (Vertical type)
-
Cylindrical extruding granulating machine
